// App-Quantinova.ai

BSH2020‐PO‐053 : Renal function over 10 years in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors: a single centre experience

Researchers

Presenter

  • R. Hinton

Principal Investigators

  • S. Arami

Medical Centers

  • Haematology, London Northwest University Hospitals NHS Trust, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

  • Renal disease

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 206

Drug/Treatment

  • Bosutinib

  • Nilotinib

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved